VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
125 hedge funds and large institutions have $2.08B invested in Verve Therapeutics in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 55 increasing their positions, 16 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
24% more funds holding
Funds holding: 101 → 125 (+24)
7.61% more ownership
Funds ownership: 93.65% → 101.26% (+7.6%)
Holders
125
Holding in Top 10
5
Calls
$16M
Puts
$4.26M
Top Buyers
| 1 | +$75.4M | |
| 2 | +$74.4M | |
| 3 | +$46.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.2M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$35.8M |
Top Sellers
| 1 | -$34.7M | |
| 2 | -$17.2M | |
| 3 | -$11.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.68M |
| 5 |
Millennium Management
New York
|
-$5.68M |